Early-stage and preclinical Alzheimer disease - PubMed (original) (raw)

Early-stage and preclinical Alzheimer disease

John C Morris. Alzheimer Dis Assoc Disord. 2005 Jul-Sep.

No abstract available

PubMed Disclaimer

Similar articles

• Shi-Jiang Li, PhD, Recipient of 2017 Alzheimer Award.
  [No authors listed] [No authors listed] J Alzheimers Dis. 2017;59(2):387-388. doi: 10.3233/JAD-179004. J Alzheimers Dis. 2017. PMID: 28731454 No abstract available.
• Kaj Blennow: the route to biomarkers and the Söderberg prize.
  Burton A. Burton A. Lancet Neurol. 2016 Aug;15(9):906. doi: 10.1016/S1474-4422(16)30097-7. Epub 2016 May 26. Lancet Neurol. 2016. PMID: 27238565 No abstract available.
• Remembering Emile Kraeplin and calling up a paradigm shift on the eve of the first century of Alzheimer's disease.
  [No authors listed] [No authors listed] Indian J Physiol Pharmacol. 2007 Jan-Mar;51(1):1-3. Indian J Physiol Pharmacol. 2007. PMID: 17877287 No abstract available.
• Neuropsychological assessment in preclinical and prodromal Alzheimer disease: a global perspective.
  Watermeyer T, Calia C. Watermeyer T, et al. J Glob Health. 2019 Jun;9(1):010317. doi: 10.7189/jogh.09.010317. J Glob Health. 2019. PMID: 31073397 Free PMC article. Review. No abstract available.
• Subjective cognitive decline: preclinical manifestation of Alzheimer's disease.
  Lin Y, Shan PY, Jiang WJ, Sheng C, Ma L. Lin Y, et al. Neurol Sci. 2019 Jan;40(1):41-49. doi: 10.1007/s10072-018-3620-y. Epub 2018 Nov 5. Neurol Sci. 2019. PMID: 30397816 Review.

Cited by

• The interplay of age, gender and amyloid on brain and cognition in mid-life and older adults.
  Borne L, Thienel R, Lupton MK, Guo C, Mosley P, Behler A, Giorgio J, Adam R, Ceslis A, Bourgeat P, Fazlollahi A, Maruff P, Rowe CC, Masters CL, Fripp J, Robinson GA, Breakspear M. Borne L, et al. Sci Rep. 2024 Nov 8;14(1):27207. doi: 10.1038/s41598-024-78308-3. Sci Rep. 2024. PMID: 39516511 Free PMC article.
• Predicting the Progression of Mild Cognitive Impairment to Alzheimer's Dementia Using Recurrent Neural Networks With a Series of Neuropsychological Tests.
  Park C, Joo G, Roh M, Shin S, Yum S, Yeo NY, Park SW, Jang JW, Im H; Alzheimer's Disease Neuroimaging Initiative. Park C, et al. J Clin Neurol. 2024 Sep;20(5):478-486. doi: 10.3988/jcn.2023.0289. J Clin Neurol. 2024. PMID: 39227330 Free PMC article.
• The impacts of sex and the 5xFAD model of Alzheimer's disease on the sleep and spatial learning responses to feeding time.
  Campbell KJ, Jiang P, Olker C, Lin X, Kim SY, Lee CJ, Song EJ, Turek FW, Vitaterna MH. Campbell KJ, et al. Front Neurol. 2024 Jul 31;15:1430989. doi: 10.3389/fneur.2024.1430989. eCollection 2024. Front Neurol. 2024. PMID: 39144714 Free PMC article.
• Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study.
  Papp KV, Maruff P, Rentz DM, Donohue MC, Liu A, Aisen PS, Sperling RA. Papp KV, et al. J Prev Alzheimers Dis. 2024;11(4):846-856. doi: 10.14283/jpad.2024.137. J Prev Alzheimers Dis. 2024. PMID: 39044493 Free PMC article. Clinical Trial.
• The Association between cognitive impairment and anthropometric indices among the elderly: birjand longitudinal aging study.
  Ramezani Kashal F, Nouredini G, Hezaveh ZS, Fakhrzadeh H, Moodi M, Khorashadizadeh M, Khodabakhshi H, Arzaghi SM, Ebrahimpour M, Payab M, Ejtahed HS, Sharifi F. Ramezani Kashal F, et al. J Diabetes Metab Disord. 2024 Mar 25;23(1):1173-1182. doi: 10.1007/s40200-024-01404-8. eCollection 2024 Jun. J Diabetes Metab Disord. 2024. PMID: 38932884

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information